Enjoy complimentary customisation on priority with our Enterprise License!
The global cell sorting market size is estimated to grow by USD 129.02 million at a CAGR of 7.86% between 2022 and 2027.
The growing prevalence of chronic diseases, such as diabetes and cancer, has increased the need for cell-based therapies. In order to understand and develop novel therapies for these conditions, this technology plays an important role. Cell sorting allows researchers and scientists to isolate specific cells from a heterogeneous cell population so that they can gain more knowledge about the mechanisms of an illness, identify bioindicators or develop targeted treatments. The increasing prevalence of chronic conditions also drives the need for precision medicine, which focuses on tailoring treatments to individual patients based on their unique biological characteristics. The demand for cell-based therapies will increase as a result of an increased incidence of medical conditions, which will boost the growth of the market during the forecast period.
To learn more about this report, Request Free Sample
The market is witnessing substantial growth fueled by technological advancements, research activities, and funding and investments worldwide. With HIV, cancer incidences, and Alzheimer's disease remaining areas of significant concern, cell sorters play a crucial role in analyzing heterogeneous mixtures with variations in cell characteristics. These advancements cater to diverse areas of interest within the global market, offering precise solutions for sorting cells based on specific criteria, thus paving the way for more effective diagnoses and treatments in various medical fields.
Technavio has segmented the market by the end-user is classified into (pharmaceutical and biotechnology companies, hospitals and clinical testing laboratories, and others); the technology is classified into (fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and micro-electromechanical systems). Also, the geography segment includes key regions such as (North America, Europe, Asia, and the Rest of the World (ROW))
The market share growth by the pharmaceutical and biotechnology companies segment will be significant during the forecast period. For the discovery of drugs, understanding of diseases, and personalized medicines, pharmaceutical and biotechnology companies are heavily dependent on research and development. Enclosure sorting plays a crucial role in the isolation of specific populations for study, ensuring the accuracy and purity of the cells used in experiments or therapies. This is particularly important when working with rare partition populations or subpopulations with specific characteristics.
Get a glance at the market contribution of various segments View a PDF Sample
The pharmaceutical and biotechnology segments were valued at USD 111.07 million in 2017. For instruments for sorting cells, providers such as Becton Dickinson and Danaher have also developed comprehensive solutions to meet the diverse needs of pharmaceutical and biotechnology companies in terms of cell analysis, including flow cytometric, reagents, and software. The increasing need for precision and accuracy in cell-based research, increased drug development efforts, and the pursuit of personalized medicine is expected to increase the demand from pharmaceutical and biotechnology companies, which will boost the growth of the market in focus through the pharmaceutical and biotechnology companies segment during the
Based on technology, the market has been segmented into fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and micro-electromechanical systems. The fluorescence-based droplet cell sorting will account for the largest share of this segment. FADS is a technique that uses fluorescence to sort partitions into individual droplets. They are first labeled with fluorescent dyes that bind to specific molecules on the enclosure surface. Then, these cells are transported via the Microfluidic device, which creates tiny droplets that contain only one cell. FADS is more efficient, sensitive, and less destructive to cells, making it ideal among these end users. Because of a number of reasons, pharmaceutical companies are increasingly demanding FADS. Increasing focus on personalized medicine and precision therapy, increased research and development activity in pharmaceutical and biotechnology industries, advancements in the field of fluorescence technology, and the rising demand for cell-based therapies are expected to fuel the growth of the FADS segment of the market during the forecast.
For more insights about the market share of various regions View PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The market in North America is growing in the US, Canada, and Mexico. In those countries, higher government funding for research and an increase in the number of Regenerative Medicine Research Institutes have contributed to this. In North America, the US has been an attractive market for investing in research. This is because of the funding provided by government departments, such as the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA), to small startups and other companies that focus on developing novel products for the treatment of healthcare conditions such as chronic diseases. Funding will contribute to the growth of the market in the region during the forecast period.
Buy Now Full Report and Discover More
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Becton Dickinson and Co. - The company offers the facsdiscover S 8 cell sorter, which is designed to obtain insights on cell populations and characteristics that can be visually confirmed in real-time.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is experiencing rapid growth driven by technological advancements and increasing research activities in BioPharmaceuticals and disease areas like HIV, cancer incidences, and Alzheimer's disease. Emerging cell sorting technologies, including flow cytometry, microfluidic technology, and novel therapeutics, are addressing the need for precise sorting based on cell size, surface protein expression, and morphology in heterogeneous mixtures. Innovations such as single cell sorting, magnetic cell sorting, IsoRaft arrays, and DEPArrays are reshaping the landscape, supported by funding and investments in this critical domain. There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The increasing prevalence of chronic diseases is driving growth in the market. The growing prevalence of chronic diseases, such as diabetes and cancer, has increased the need for such therapies. Sorting technology plays a crucial role in understanding and finding innovative treatments for these conditions. Cell sorting allows physicians and scientists to identify specific from a range of different types, enabling them to gain more information about disease mechanisms, discover immunological markers as well as develop targeted treatments. Understanding these interactions can lead to the development of more effective treatments and personalized medicine approaches.
However, cell sorting enables the isolation of specific populations, which can be characterized and analyzed further to identify biomarkers or develop personalized therapeutic strategies. The demand for such as stem cell therapy and immunotherapies is growing because of an increase in chronic disease burden worldwide. In order to ensure the safety and efficacy of the final cell-based products, cell sorting technology enables the isolation and enrichment of specific types for use in these therapies. Thus, the growing prevalence of chronic conditions will increase the demand for cell-based therapies, which will boost the growth of the market during the forecast period.
The growing adoption of genetic engineering in forensic research is a primary trend in the market. Forensic testing of evidence is also becoming increasingly important due to increasing crime rates across the world. In 2017, the homicide rate in OECD countries was around 4.9 per 100,000 inhabitants, which is higher than the average of 3.6 in the US, according to the Organization for Economic Co-operation and Development (OECD). This increase in homicide rates has increased investments in forensic research.
Moreover, genetic profiling is an advanced technology that is increasingly being used in forensics. Genotyping technologies, even from very minute biological evidence found at crime scenes, allow investigators to obtain a reliable genetic profile of the offender and his or her identity. Isolation and genetic analysis of pure partitions from biological mixtures is one of the most important steps in forensic genetic profiling. Therefore, the growing adoption of genetic engineering in forensic investigations will increase the demand for such isolation, which, in turn, will boost the growth of the market during the forecast period.
The lack of trained laboratory professionals is a major challenge in the market. In experiments involving cell isolation techniques, it is necessary to perform accurate analyses and interpretations in order to obtain reliable results. The correlation of experimental results with the hypothesis on which the experiment is based is equally important. Therefore, cell isolation experiments must be performed only by people with relevant expertise. As developing countries lack adequately trained laboratory professionals, the adoption of these experiments is low in these regions. Training on the latest technology and laboratory equipment, or awareness of its benefits, is not commonly available to almost all lab technicians.
Also, laboratory professionals who handle technologically advanced diagnostic devices lack the adequate training that is needed to achieve optimal results. The probability of a wrong diagnosis is increased by the lack of expertise. The lack of expertise may lead to false results at research laboratories. Hence, the shortage of trained professionals will have a negative impact on the growth of the market in focus during the forecast period.
Buy Now Full Report and Discover More
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Market Customer Landscape
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
The market is witnessing significant growth propelled by advancements in microfluidics technology and stem cell research, driving demand for cell sorting instruments. Research institutions, academic laboratories, and hospitals are key users despite budgetary constraints and the need for skilled personnel. Companies like Beckman Coulter lead in providing solutions like magnetic activated cell sorting (MACS), alongside a range of reagents and consumables. Clinical applications are expanding, especially in heterogeneous mixture analysis and targeted therapies, supported by rising healthcare expenditure in emerging economies.
Additionally, collaboration with pharma companies and medical schools facilitates product development, furthering immunology research and proteomics advancements, especially in isolating single tumor cells for diagnostics and therapeutic interventions. Further, in the burgeoning market, demand surges from academic research laboratories, hospitals testing laboratories, and biology laboratories utilizing molecular biological techniques. Providers offer Cell Sorting Reagents and Cell Sorting Services, facilitating efficient separation for diverse applications, from fundamental research to clinical diagnostics, driving innovation in biotechnology and healthcare.
Market Scope |
|
Report Coverage |
Details |
Page number |
155 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 7.86% |
Market growth 2023-2027 |
USD 129.02 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
7.14 |
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
Performing market contribution |
North America at 37% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Becton Dickinson and Co., Bio Rad Laboratories Inc., Bulldog-Bio Inc., Cell Microsystems Inc., Cytonome ST LLC, Danaher Corp., Guandong Benice Intelligent Equipment Co.Ltd., Miltenyi Biotec B.V. and Co. KG, Molecular Device LLC, Namocell Inc., NanoCellect Biomedical Inc., On-Chip Biotechnologies Co. Ltd., Semco Infratech Pvt. Ltd., Sony Group Corp., STEMCELL Technologies Inc., Terumo Corp., Thermo Fisher Scientific Inc., Union Biometrica Inc., Xiamen Tmax Battery Equipments Ltd., and Xiamen WinAck Battery Technology Co. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
View Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Technology
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.